Kate E Wallis1,2,3, Christina Mulé4,5, Shruti Mittal6, Natalie Cerda7, Rebecca Shaffer8, Angela Scott9, Diane Langkamp10,11, Marilyn Augustyn12, Ellen Perrin13, Neelkamal Soares14, Nathan J Blum1,2. 1. Division of Developmental and Behavioral Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA. 2. Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. 3. PolicyLab, Children's Hospital of Philadelphia, Philadelphia, PA. 4. Department of Pediatrics, University of Rochester Medical Center, Rochester, NY. 5. Department of Pediatrics, Tufts University School of Medicine, Boston, MA. 6. Developmental and Behavioral Pediatrics of the Carolinas, Atrium Health, Charlotte, NC. 7. Developmental Medicine Center, Boston Children's Hospital, Boston, MA. 8. Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati Medical School, Cincinnati, OH. 9. Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR. 10. NeuroDevelopmental Science Center, Akron Children's Hospital, Akron, OH. 11. Department of Pediatrics, Northeast Ohio Medical University, Rootstown, OH. 12. Division of Developmental and Behavioral Pediatrics, Boston Medical Center, Boston University School of Medicine, Boston, MA. 13. Division of Developmental-Behavioral Pediatrics, Tufts Children's Hospital, Boston, MA. 14. Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, MI.
Abstract
OBJECTIVE: This study aims to describe the use of telehealth in developmental behavioral pediatric (DBP) fellowship-affiliated practices during the coronavirus disease 2019 (COVID-19) global pandemic. METHODS: An electronic survey was disseminated to all DBP fellowship-associated practice locations to determine the use of telehealth in DBP care provision, before and since the beginning of the COVID-19 pandemic. We analyzed responses using descriptive statistics. RESULTS: A total of 35 of 42 eligible practice sites responded (83% response rate). Most sites (51.4%) reported using telehealth less than once per month before the COVID-19 pandemic. Since the onset of COVID-19, 100% of programs reported conducting video-based telehealth visits multiple days per week. Most sites reported conducting evaluations and follow-up visits for attention-deficit/hyperactivity disorder, autism spectrum disorder, behavioral concerns, developmental delay, genetic disorders, and learning disability. Most sites were able to continue medication management by telehealth (>88%), offer interpreter services for families with limited English proficiency participating in telehealth visits (>90%), and incorporate trainees and interdisciplinary team members in telehealth visits (>90%). Greater variability was observed in sites' ability to collect telehealth practice evaluation measures. CONCLUSION: Most sites are providing evaluations and ongoing care for DBP conditions through telehealth. The rapid adoption of telehealth can have ramifications for the way that DBP care is delivered in the future; therefore, it is imperative to understand current practice patterns and variations to determine the best use of telehealth.
OBJECTIVE: This study aims to describe the use of telehealth in developmental behavioral pediatric (DBP) fellowship-affiliated practices during the coronavirus disease 2019 (COVID-19) global pandemic. METHODS: An electronic survey was disseminated to all DBP fellowship-associated practice locations to determine the use of telehealth in DBP care provision, before and since the beginning of the COVID-19 pandemic. We analyzed responses using descriptive statistics. RESULTS: A total of 35 of 42 eligible practice sites responded (83% response rate). Most sites (51.4%) reported using telehealth less than once per month before the COVID-19 pandemic. Since the onset of COVID-19, 100% of programs reported conducting video-based telehealth visits multiple days per week. Most sites reported conducting evaluations and follow-up visits for attention-deficit/hyperactivity disorder, autism spectrum disorder, behavioral concerns, developmental delay, genetic disorders, and learning disability. Most sites were able to continue medication management by telehealth (>88%), offer interpreter services for families with limited English proficiency participating in telehealth visits (>90%), and incorporate trainees and interdisciplinary team members in telehealth visits (>90%). Greater variability was observed in sites' ability to collect telehealth practice evaluation measures. CONCLUSION: Most sites are providing evaluations and ongoing care for DBP conditions through telehealth. The rapid adoption of telehealth can have ramifications for the way that DBP care is delivered in the future; therefore, it is imperative to understand current practice patterns and variations to determine the best use of telehealth.
Authors: Helene Kreysa; Dana Schneider; Andrea Erika Kowallik; Samaneh Sadat Dastgheib; Cem Doğdu; Gabriele Kühn; Jenny Marianne Ruttloff; Stefan R Schweinberger Journal: Healthcare (Basel) Date: 2022-04-12
Authors: Maria Piane; Lavinia Bianco; Rita Mancini; Paolo Fornelli; Angela Gabriele; Francesco Medici; Claudia Battista; Stefania Greco; Giuseppe Croce; Laura Franceschetti; Christian Napoli; Mario Ronchetti; Paolo Anibaldi; Giorgio Banchieri Journal: Int J Environ Res Public Health Date: 2022-01-06 Impact factor: 4.614